Operating income Jubilant Life Sciences Limited is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Jubilant Life Sciences Limited is 3 939 600 000 Rs Net income Jubilant Life Sciences Limited is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Jubilant Life Sciences Limited is 2 033 800 000 Rs
|
31/12/2019
|
30/09/2019
|
30/06/2019
|
31/03/2019
|
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
|
14 184 500 000 Rs |
13 679 000 000 Rs |
13 147 200 000 Rs |
17 663 870 000 Rs |
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
|
8 967 600 000 Rs |
8 980 300 000 Rs |
8 671 400 000 Rs |
6 191 900 000 Rs |
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
|
23 152 100 000 Rs |
22 659 300 000 Rs |
21 818 600 000 Rs |
23 855 770 000 Rs |
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
|
23 152 100 000 Rs |
22 659 300 000 Rs |
21 818 600 000 Rs |
23 855 770 000 Rs |
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
|
3 939 600 000 Rs |
3 516 100 000 Rs |
3 319 100 000 Rs |
2 874 900 000 Rs |
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
|
2 033 800 000 Rs |
2 493 900 000 Rs |
1 849 800 000 Rs |
-992 940 000 Rs |
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
|
- |
- |
- |
- |
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
|
19 212 500 000 Rs |
19 143 200 000 Rs |
18 499 500 000 Rs |
20 980 870 000 Rs |
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
|
- |
46 240 300 000 Rs |
- |
45 847 990 000 Rs |
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
|
- |
118 925 700 000 Rs |
- |
114 685 050 000 Rs |
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
|
- |
13 634 700 000 Rs |
- |
10 053 970 000 Rs |
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
|
- |
21 368 600 000 Rs |
- |
20 897 290 000 Rs |
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
|
- |
- |
- |
- |
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
|
- |
66 622 700 000 Rs |
- |
66 594 890 000 Rs |
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
|
- |
56.02 % |
- |
58.07 % |
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
|
52 303 000 000 Rs |
52 303 000 000 Rs |
48 089 200 000 Rs |
48 089 170 000 Rs |
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
|
- |
- |
- |
- |